loading animation for AJAX calls
Items per page:   25 | 50 | 75 | 100

149 Reports in Pharmaceuticals

Antiemetics: Technologies and Global Markets

Published - Aug 2018 | Analyst - BCC Research Staff| Code - PHM070B

The global market for antiemetics reached $4.1 billion in 2017 and should reach $5.9 billion by 2022, at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2018-2023.

Pharmaceuticals for Women's Health: Global Markets to 2023

Published - Aug 2018 | Analyst - BCC Research Staff| Code - PHM203A

The global market for women’s health therapeutics reached nearly $30.5 billion in 2018 and should reach nearly $37.3 billion by 2023, at a compound annual growth rate (CAGR) of 4.2% for the period of 2018-2023. 

Cognition and Memory Enhancement Drugs: Technologies and Global M...

Published - Jul 2018 | Analyst - Sangeeta Rai| Code - PHM184A

The global cognition and memory-enhancing drugs market should reach over $4.2 billion by 2022 from $2.8 billion in 2017 at a compound annual growth rate (CAGR) of 8.7% for the period 2017-2022.

Active Pharmaceutical Ingredients: Global Markets to 2022

Published - Jul 2018 | Analyst - BCC Research Staff| Code - PHM200A

The global active pharmaceutical ingredient (API) market should reach $154.7 billion by 2022 from $114.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.2% for the period 2017-2022.

Neuroprotective Agents: Therapeutic Applications and Global Marke...

Published - Jul 2018 | Analyst - Ufuk Ezer| Code - PHM188A

The global market for neuroprotective agents will grow from $54.4 billion in 2017 to $75.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.8% for the period of 2017-2022.

Antiulcerant Drugs: Global Markets to 2022

Published - Jun 2018 | Analyst - BCC Research Reference Staff| Code - PHM202A

The global antiulcerant drugs market will grow from $33.0 billion in 2017 to $37.4 billion by 2022 with a compound annual growth rate (CAGR) of 2.5% for the period of 2017-2022.

Clinical Nutrition: Global Markets to 2022

Published - May 2018 | Analyst - BCC Research Staff| Code - PHM198A

The global clinical nutrition market should reach $60.8 billion by 2022 from $48.2 billion in 2017 at a compound annual growth rate (CAGR) of 4.8% for the period 2017-2022.

The Global Influenza Market

Published - May 2018 | Analyst - Melissa Elder| Code - PHM049E

The global influenza market was valued at nearly $5.6 billion in 2017 and is expected to reach nearly $6.5 billion by 2022, increasing at a compound annual growth rate (CAGR) of 3.0% from 2017 through 2022.

Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global...

Published - May 2018 | Analyst - Usha Nagavarapu| Code - PHM153B

The global market for circulating tumor cell technology will grow from nearly $4.6 billion in 2017 to around $10.3 billion by 2022 with a compound annual growth rate (CAGR) of 17.6% for the period of 2017-2022.

Excipients in Pharmaceuticals: Global Markets to 2022

Published - May 2018 | Analyst - BCC Research Staff| Code - PHM010K

The global market for pharmaceutical excipients will grow from nearly $6.8 billion in 2017 to $8.7 billion by 2022 with a compound annual growth rate (CAGR) of 4.9% for the period of 2017-2022.

Drugs for Urinary Incontinence and Overactive Bladder: Global Mar...

Published - Apr 2018 | Analyst - BCC Research Reference Staff| Code - PHM199A

The global drugs for urinary incontinence and overactive bladder market should reach $4.2 billion by 2022 from $3.6 billion in 2017 at a compound annual growth rate (CAGR) of 2.9%, from 2017 to 2022.

Muscle Relaxants: Global Markets to 2022

Published - Apr 2018 | Analyst - BCC Research Reference Staff| Code - PHM196A

The global muscle relaxants market totaled $18.4 billion in 2017 and is estimated to reach $24.4 billion by 2022, growing at a compound annual growth rate (CAGR) of 5.8% for the period of 2017-2022. 

Anti-Epileptic Drugs: Global Markets to 2022

Published - Apr 2018 | Analyst - BCC Research Reference Staff| Code - PHM197A

The global anti-epileptic drugs market totaled $8.4 billion in 2017 and is estimated to reach $9.5 billion by 2022, growing at a compound annual growth rate (CAGR) of 2.7% for the period of 2017-2022.

Drugs for Infertility: Global Markets to 2022

Published - Apr 2018 | Analyst - BCC Research Reference Staff| Code - PHM194A

The global market for drugs for infertility should reach $4.2 billion by 2022 from $3.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.3%, from 2017 to 2022.

Global Markets for Vaccine Technologies

Published - Apr 2018 | Analyst - Anuj Pathak| Code - PHM014G

The global market for vaccine technologies reached $35.7 billion in 2017 and should reach nearly $46.6 billion by 2022, at a compound annual growth rate (CAGR) of 5.5% for the period of 2017-2022.

Cardiovascular Drugs: Global Markets to 2022

Published - Apr 2018 | Analyst - BCC Research Staff| Code - PHM191A

The global cardiovascular drugs market should reach $149.4 billion by 2022 from $141.1 billion in 2017 at a compound annual growth rate (CAGR) of 1.2%, from 2017 to 2022.

Drugs for Rheumatoid Arthritis: Global Markets to 2022

Published - Apr 2018 | Analyst - BCC Research Reference Staff| Code - PHM195A

The global rheumatoid arthritis drugs market totaled $1.7 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 6.6% for the period of 2017-2022.

Global Markets for Contract Pharmaceutical Manufacturing, Researc...

Published - Apr 2018 | Analyst - Shalini Shahani Dewan| Code - PHM043G

The global market for pharmaceutical contract manufacturing, contract research and contract packaging will grow from $136.4 billion in 2017 to $197.0 billion by 2022 with a compound annual growth rate (CAGR) of 7.6% for the period of 2017-2022.

Anti-Parkinson's Drugs: Global Markets to 2022

Published - Apr 2018 | Analyst - BCC Research Reference Staff| Code - PHM193A

The global anti-Parkinson’s drugs market should reach $5.7 billion by 2022 from $4.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.1% from 2017 to 2022.

Global Markets for Infectious Disease Treatments

Published - Mar 2018 | Analyst - Megha Joshi-Sood| Code - PHM061D

The global market for infectious disease treatments totaled $64.8 billion in 2017. The market should total $99 billion by 2022, growing at a compound annual growth rate (CAGR) of 8.9% from 2017 to 2022.

Global Cancer Therapeutics Market: Emphasis on Recurrent and Meta...

Published - Dec 2017 | Analyst - Paul Taylor| Code - PHM177A

The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022.

Medication Adherence: Systems, Technologies and Global Markets

Published - Nov 2017 | Analyst - Dr. Ritu Thakur Dangi| Code - PHM182A

The global market for medication adherence reached $1.7 billion in 2016 and should reach nearly $4.0 billion by 2021 at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021.

Substance Abuse and Addiction Treatment, Global Markets to 2021

Published - Aug 2017 | Analyst - Yojana Jeevane| Code - PHM035C

The global substance abuse and addiction treatment market reached $3.1 billion in 2016 and should reach nearly $4.4 billion in 2021, at a compound annual growth rate (CAGR) of 7.0%.

Antibody Drug Conjugates: Technologies and Global Markets

Published - Jun 2017 | Analyst - Shalini Shahani Dewan| Code - PHM161B

The global market for antibody drug conjugates was valued at $1.3 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 25.5% from 2016 to 2021.

The Chinese Market for Cancer Intervention

Published - Jun 2017 | Analyst - Jason Chen| Code - PHM179A

The Chinese cancer intervention market reached nearly $41.1 billion in 2016. This market should reach $46.7 billion in 2017 and $89.3 billion by 2022, at a compound annual growth rate (CAGR) of 13.8% through 2022.

13 Upcoming Reports in Pharmaceuticals

Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases

Target Date - Aug 2018| Author - BCC Research Staff| Code - PHM005D| Price - $5,500

Report Includes

  • An overview of the global market scenario for diagnosis and treatments of sexually transmitted diseases
  • Country specific data and analysis for United States, Canada, Mexico, France, Germany, U.K., Spain, China, India, Japan, Middle East and Africa
  • Market breakdown in value terms for regional and country level with details on test types, disease areas, and treatment by drug class etc.
  • Key sectional assessments for major disease areas such as chlamydia, genital herpes, HIV, hepatitis, among others and a detailed analysis of epidemiology, historic and current disease incidence trends, therapeutic interventions, and diagnostic overview
  • Discussion about market dynamics such as drivers, restraints, and trends along with regulatory scenario for United States, Europe, Japan and China to provide overview of the regulations for new drug launches and diagnostic kits
  • Examination of competitive landscape and profiles of the major manufacturers involved in the sexually transmitted disease therapeutics market, key developments and their product offerings

Notify Me

 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM